Renaissance Technologies’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $288K | Buy |
+292,400
| New | +$288K | ﹤0.01% | 3056 |
|
2025
Q1 | – | Sell |
-578,800
| Closed | -$1.27M | – | 3560 |
|
2024
Q4 | $1.27M | Sell |
578,800
-335,300
| -37% | -$738K | ﹤0.01% | 2345 |
|
2024
Q3 | $1.51M | Sell |
914,100
-507,800
| -36% | -$838K | ﹤0.01% | 2198 |
|
2024
Q2 | $3.16M | Sell |
1,421,900
-694,600
| -33% | -$1.54M | 0.01% | 1586 |
|
2024
Q1 | $5.67M | Buy |
2,116,500
+696,400
| +49% | +$1.87M | 0.01% | 1338 |
|
2023
Q4 | $4.25M | Buy |
1,420,100
+1,213,944
| +589% | +$3.63M | 0.01% | 1454 |
|
2023
Q3 | $202K | Buy |
206,156
+91,856
| +80% | +$90K | ﹤0.01% | 3090 |
|
2023
Q2 | $159K | Buy |
+114,300
| New | +$159K | ﹤0.01% | 3341 |
|
2022
Q4 | – | Sell |
-286,700
| Closed | -$1.92M | – | 4183 |
|
2022
Q3 | $1.92M | Sell |
286,700
-98,600
| -26% | -$661K | ﹤0.01% | 2042 |
|
2022
Q2 | $2.45M | Sell |
385,300
-36,900
| -9% | -$235K | ﹤0.01% | 2039 |
|
2022
Q1 | $1.96M | Buy |
+422,200
| New | +$1.96M | ﹤0.01% | 2245 |
|
2019
Q4 | – | Sell |
-141,900
| Closed | -$5.2M | – | 3558 |
|
2019
Q3 | $5.2M | Sell |
141,900
-95,600
| -40% | -$3.5M | ﹤0.01% | 1770 |
|
2019
Q2 | $11M | Buy |
237,500
+41,905
| +21% | +$1.95M | 0.01% | 1334 |
|
2019
Q1 | $7.85M | Buy |
195,595
+177,695
| +993% | +$7.13M | 0.01% | 1512 |
|
2018
Q4 | $823K | Buy |
+17,900
| New | +$823K | ﹤0.01% | 2668 |
|
2017
Q4 | – | Sell |
-14,500
| Closed | -$727K | – | 3378 |
|
2017
Q3 | $727K | Buy |
+14,500
| New | +$727K | ﹤0.01% | 2685 |
|
2016
Q4 | – | Sell |
-318,800
| Closed | -$4.42M | – | 3297 |
|
2016
Q3 | $4.42M | Buy |
+318,800
| New | +$4.42M | 0.01% | 1683 |
|
2016
Q2 | – | Sell |
-107,600
| Closed | -$1.82M | – | 3374 |
|
2016
Q1 | $1.82M | Sell |
107,600
-253,600
| -70% | -$4.29M | ﹤0.01% | 2279 |
|
2015
Q4 | $8.04M | Buy |
+361,200
| New | +$8.04M | 0.02% | 1140 |
|